Novo Nordisk A/S
NVO News Today: Stay Updated with the Latest Novo Nordisk A/S News in Real Time
Find NVO news now at Meyka AI. Stay informed with the latest Novo Nordisk A/S stocks updates, including price news, market analysis, and expert insights.
MRK Stock April 26: Merck Clears $6.7B Terns Acquisition
Merck clears HSR approval for $6.7B Terns Pharmaceuticals acquisition. MRK stock gains as regulatory hurdle expires.
LLY Stock April 25: Foundayo Obesity Pill Struggles Against Novo
LLY stock faces headwinds as Foundayo lags Novo’s Wegovy. Explore Eli Lilly’s GLP-1 strategy, competition, and investment implications.
AGIO Maintained at Buy by H.C. Wainwright, April 2026
H.C. Wainwright maintains Buy rating on AGIO, cuts price target following Novo data impact on hemolytic anemia market.
Shengda Tech IPO April 20: Soars 59% in Dark Trading
Shengda Tech IPO April 20: Stock soars 59% in dark trading. Nvidia PCB supplier debuts April 21 on Hong Kong Exchange with massive investor demand.
EVT.SW Stock Surges 11.68% on April 17, 2026 – Evotec SE Gains
EVT.SW stock jumps 11.68% to CHF 5.115 on SIX. Evotec SE shows strong intraday gains despite D+ rating. Real-time analysis inside.
PA8.F Stock Surges 62.5% in After-Hours Trading on April 15
PA8.F stock jumps 62.5% to €0.065 in after-hours session. Paion AG shows strong volume activity on XETRA. Analysis and market sentiment inside.
IPH.PA stock surges 13.7% on April 14 as biotech gains momentum
IPH.PA stock jumps 13.7% to €1.36 on EURONEXT. Innate Pharma gains as biotech sector shows strength with clinical pipeline progress.
Evotec SE (EVT.DE XETRA) 06 Apr 2026 earnings preview: valuation test ahead
EVT.DE stock trades at EUR 4.50 ahead of 08 Apr 2026 earnings; we review guidance risks, Meyka forecast and price targets for traders
EVT.DE Evotec SE (XETRA) pre-market 03 Apr 2026: Q4 results due 08 Apr, catalyst ahead
EVT.DE stock pre-market snapshot and earnings spotlight ahead of 08 Apr 2026 results